Advion BioSystems and Agilent Technologies Announce Co-Marketing Agreement
News Nov 18, 2008
Advion BioSystems, Inc. and Agilent Technologies Inc. have jointly announced that they have signed a non-exclusive co-marketing agreement to co-promote the Advion TriVersa NanoMate system with Agilent mass spectrometers.
The TriVersa NanoMate is an automated fraction collection and nanoelectrospray system that connects to the inlet of a mass spectrometer. It combines the benefits of micro or capillary-scale liquid chromatography (LC), with simultaneous fraction collection and subsequent chip-based infusion of the LC fractions in one system to increase the performance and automation of a mass spectrometer.
The TriVersa NanoMate differs from Agilent’s 1200 Series HPLC-Chips in that the former operates at capillary and micro flow rates needed for fraction collection, enabling collection of individual peaks for highly sensitive infusion MS analysis. The latter provides on-line LC/MS at nanoflow rates that are well-suited to applications where the amount of sample available is limited.
Agilent and Advion have co-developed a bracket to interface the TriVersa NanoMate to Agilent mass spectrometers to provide life science users with the power of automated sample infusion on the Agilent family of LC/MS systems.
Under the agreement, the companies will co-market the TriVersa NanoMate and Agilent mass spectrometer systems with each company responsible for its individual products.
Agilent will sell and support its mass spectrometers and Advion will sell and support the TriVersa NanoMate and the bracket to interface the TriVersa NanoMate to Agilent mass spectrometers. Each company will co-promote their products at industry tradeshows and conferences.
“The combination of the TriVersa NanoMate with Agilent mass spectrometers provides a powerful tool for life science researchers,” said Jack Henion, Advion’s Chief Scientific Officer. “In particular, the efficiency and sensitivity of direct infusion of LC fractions with the TriVersa NanoMate and the new Agilent 6530 Accurate-Mass Q-TOF instrument provides researchers with exceptional sensitivity and speed for proteomics, metabolism, lipidomics, and biomarker applications.”
Test For Designer Drugs Could Help Treat Overdose PatientsNews
Medical professionals are scrambling to meet the growing demand for emergency room treatment, but they’re hampered by the lack of a quick and easy test to screen patients for “designer” drugs. Chemists have now developed such a test and are refining it with the hope that hospitals could eventually use it to choose the appropriate treatment.READ MORE
Measuring Neutrophil Motility Could Lead to Accurate Sepsis DiagnosisNews
Mass. General researchers design device that rapidly diagnoses sepsis with more than 95 percent accuracy.READ MORE
Comments | 0 ADD COMMENT
11th International Conference and Exhibition on Metabolomics & Systems Biology
May 17 - May 19, 2018
World Congress on Plant Science and Molecular Biology
Sep 12 - Sep 13, 2018
10th International Conference on Mass Spectrometry and Chromatography
Oct 08 - Oct 09, 2018